{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:01:21Z","timestamp":1788368481452,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Schleswig-Holstein - Campus Kiel"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j intensive care"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Treatment effect of high-dose intravenous selenium remains controversial in patients with sepsis or septic shock. Here, we reanalyzed data from the randomized placebo-controlled trial of Sodium Selenite and Procalcitonin Guided Antimicrobial Therapy in Severe Sepsis (SISPCT) to reveal possible treatment differences according to established sepsis phenotypes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this secondary data analysis of the SISPCT trial all 1089 patients of the original study were included. Patients were assigned to one of the four phenotypes by comparing patient variables with the Sepsis Endotyping in Emergency Care (SENECA) validation cohort. Survival analyses were performed using Kaplan\u2013Meier and log-rank tests.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>No robust effect of selenium on mortality and other outcome parameters could be determined in any sepsis phenotype. Phenotype frequencies were markedly different in our study cohort compared to previous reports (<jats:italic>\u03b1<\/jats:italic>: 2.2%, <jats:italic>\u03b2<\/jats:italic>: 6.3%, <jats:italic>\u03b3<\/jats:italic>: 68.0%, <jats:italic>\u03b4<\/jats:italic>: 23.4%). Differences in mortality between the respective phenotypes were not significant overall; however, 28-day mortality showed a lower mortality for the <jats:italic>\u03b1<\/jats:italic>- (20.8%) and <jats:italic>\u03b2<\/jats:italic>-phenotype (20.3%), followed by the <jats:italic>\u03b3<\/jats:italic>- (27.1%), and <jats:italic>\u03b4<\/jats:italic>-phenotype (28.5%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Application of the four sepsis phenotypes to the SISPCT study cohort showed discrete but non-significant mortality differences within 28\u00a0days. However, beneficial treatment effects of high-dose intravenous selenium were still not detectable after categorizing the SISPCT study cohort according to four phenotype criteria.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40560-025-00790-2","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T06:37:53Z","timestamp":1744612673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Treatment effect of intravenous high-dose selenium in sepsis phenotypes: a retrospective analysis of a large multicenter randomized controlled trial"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9189-5747","authenticated-orcid":false,"given":"David I.","family":"Radke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Bogatsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7247-282X","authenticated-orcid":false,"given":"Christoph","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0767-7941","authenticated-orcid":false,"given":"Frank","family":"Bloos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2666-8696","authenticated-orcid":false,"given":"Patrick","family":"Meybohm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1521-3514","authenticated-orcid":false,"given":"Michael","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Lulu","family":"Homayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2028-2039","authenticated-orcid":false,"given":"Christian","family":"Stoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4948-1605","authenticated-orcid":false,"given":"Gunnar","family":"Elke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2647-7790","authenticated-orcid":false,"given":"Matthias","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the SepNet Critical Care Trials Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Nierhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Briegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Jaschinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onnen","family":"M\u00f6rer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Weyland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Gr\u00fcndling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kluge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Utzolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Stehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Ragaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Brunkhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herwig","family":"Gerlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"issue":"10219","key":"790_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200\u201311.","journal-title":"Lancet"},{"issue":"2","key":"790_CR2","doi-asserted-by":"publisher","first-page":"R66","DOI":"10.1186\/cc11316","volume":"16","author":"W Manzanares","year":"2012","unstructured":"Manzanares W, Dhaliwal R, Jiang X, Murch L, Heyland DK. Antioxidant micronutrients in the critically ill: a systematic review and meta-analysis. Crit Care. 2012;16(2):R66.","journal-title":"Crit Care"},{"issue":"7","key":"790_CR3","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1007\/s00134-011-2212-6","volume":"37","author":"W Manzanares","year":"2011","unstructured":"Manzanares W, Biestro A, Torre MH, Galusso F, Facchin G, Hardy G. High-dose selenium reduces ventilator-associated pneumonia and illness severity in critically ill patients with systemic inflammation. Intensive Care Med. 2011;37(7):1120\u20137.","journal-title":"Intensive Care Med"},{"issue":"5","key":"790_CR4","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s00134-011-2153-0","volume":"37","author":"J Valenta","year":"2011","unstructured":"Valenta J, Brodska H, Drabek T, Hendl J, Kazda A. High-dose selenium substitution in sepsis: a prospective randomized clinical trial. Intensive Care Med. 2011;37(5):808\u201315.","journal-title":"Intensive Care Med"},{"issue":"2","key":"790_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.abb.2013.02.021","volume":"536","author":"H Steinbrenner","year":"2013","unstructured":"Steinbrenner H, Sies H. Selenium homeostasis and antioxidant selenoproteins in brain: implications for disorders in the central nervous system. Arch Biochem Biophys. 2013;536(2):152\u20137.","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"790_CR6","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1097\/CCM.0b013e31828a24c6","volume":"41","author":"W Alhazzani","year":"2013","unstructured":"Alhazzani W, Jacobi J, Sindi A, Hartog C, Reinhart K, Kokkoris S, et al. The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med. 2013;41(6):1555\u201364.","journal-title":"Crit Care Med"},{"issue":"1","key":"790_CR7","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/01.CCM.0000251124.83436.0E","volume":"35","author":"MWA Angstwurm","year":"2007","unstructured":"Angstwurm MWA, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, et al. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med. 2007;35(1):118\u201326.","journal-title":"Crit Care Med"},{"issue":"9","key":"790_CR8","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jamainternmed.2016.2514","volume":"176","author":"F Bloos","year":"2016","unstructured":"Bloos F, Trips E, Nierhaus A, Briegel J, Heyland DK, Jaschinski U, et al. Effect of sodium selenite administration and procalcitonin-guided therapy on mortality in patients with severe sepsis or septic shock: a randomized clinical Trial. JAMA Intern Med. 2016;176(9):1266\u201376.","journal-title":"JAMA Intern Med"},{"issue":"16","key":"790_CR9","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1056\/NEJMoa1212722","volume":"368","author":"D Heyland","year":"2013","unstructured":"Heyland D, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, et al. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med. 2013;368(16):1489\u201397.","journal-title":"N Engl J Med"},{"issue":"1","key":"790_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13054-021-03872-3","volume":"26","author":"SY Jung","year":"2022","unstructured":"Jung SY, Lee MT, Baek MS, Kim WY. Vitamin C for \u2265 5 days is associated with decreased hospital mortality in sepsis subgroups: a nationwide cohort study. Crit Care. 2022;26(1):3.","journal-title":"Crit Care"},{"issue":"6","key":"790_CR11","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41591-022-01843-x","volume":"28","author":"DM Maslove","year":"2022","unstructured":"Maslove DM, Tang B, Shankar-Hari M, Lawler PR, Angus DC, Baillie JK, et al. Redefining critical illness. Nat Med. 2022;28(6):1141\u20138.","journal-title":"Nat Med"},{"issue":"20","key":"790_CR12","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","volume":"321","author":"CW Seymour","year":"2019","unstructured":"Seymour CW, Kennedy JN, Wang S, Chang CCH, Elliott CF, Xu Z, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA. 2019;321(20):2003\u201317.","journal-title":"JAMA"},{"issue":"1","key":"790_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/s13054-021-03813-0","volume":"25","author":"JL Vincent","year":"2021","unstructured":"Vincent JL, Singer M, Einav S, Moreno R, Wendon J, Teboul JL, et al. Equilibrating SSC guidelines with individualized care. Crit Care. 2021;25(1):397.","journal-title":"Crit Care"},{"issue":"9","key":"790_CR14","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S2213-2600(18)30279-0","volume":"6","author":"JG Laffey","year":"2018","unstructured":"Laffey JG, Kavanagh BP. Negative trials in critical care: why most research is probably wrong. Lancet Respir Med. 2018;6(9):659\u201360.","journal-title":"Lancet Respir Med"},{"issue":"Suppl 3","key":"790_CR15","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s13054-017-1910-z","volume":"21","author":"JL Vincent","year":"2017","unstructured":"Vincent JL. The coming era of precision medicine for intensive care. Crit Care. 2017;21(Suppl 3):314.","journal-title":"Crit Care"},{"issue":"9","key":"790_CR16","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1080\/17512433.2019.1643235","volume":"12","author":"JL Vincent","year":"2019","unstructured":"Vincent JL, Sakr Y. Clinical trial design for unmet clinical needs: a spotlight on sepsis. Expert Rev Clin Pharmacol. 2019;12(9):893\u2013900.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"790_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.clnesp.2020.11.026","volume":"41","author":"MA Mousavi","year":"2021","unstructured":"Mousavi MA, Saghaleini SH, Mahmoodpoor A, Ghojazadeh M, Mousavi SN. Daily parenteral selenium therapy in critically ill patients: an updated systematic review and meta-analysis of randomized controlled trials. Clin Nutr ESPEN. 2021;41:49\u201358.","journal-title":"Clin Nutr ESPEN"},{"issue":"3","key":"790_CR18","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.clnu.2020.06.033","volume":"40","author":"KK Gudivada","year":"2021","unstructured":"Gudivada KK, Kumar A, Shariff M, Sampath S, Varma MM, Sivakoti S, et al. Antioxidant micronutrient supplementation in critically ill adults: a systematic review with meta-analysis and trial sequential analysis. Clin Nutr. 2021;40(3):740\u201350.","journal-title":"Clin Nutr"},{"key":"790_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.clnesp.2021.12.015","volume":"47","author":"KK Gudivada","year":"2022","unstructured":"Gudivada KK, Kumar A, Sriram K, Baby J, Shariff M, Sampath S, et al. Antioxidant micronutrient supplements for adult critically ill patients: a Bayesian multiple treatment comparisons meta-analysis. Clin Nutr ESPEN. 2022;47:78\u201388.","journal-title":"Clin Nutr ESPEN"},{"issue":"3","key":"790_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/jamasurg.2022.6855","volume":"158","author":"C Stoppe","year":"2023","unstructured":"Stoppe C, McDonald B, Meybohm P, Christopher KB, Fremes S, Whitlock R, et al. Effect of high-dose selenium on postoperative organ dysfunction and mortality in cardiac surgery patients: the SUSTAIN CSX randomized clinical trial. JAMA Surg. 2023;158(3):235\u201344.","journal-title":"JAMA Surg"},{"issue":"11","key":"790_CR21","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1164\/rccm.201307-1380CP","volume":"188","author":"M Jain","year":"2013","unstructured":"Jain M, Chandel NS. Rethinking antioxidants in the intensive care unit. Am J Respir Crit Care Med. 2013;188(11):1283\u20135.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"790_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJMoa070716","volume":"358","author":"FM Brunkhorst","year":"2008","unstructured":"Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358(2):125\u201339.","journal-title":"N Engl J Med"},{"issue":"22","key":"790_CR23","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1001\/jama.2012.5833","volume":"307","author":"FM Brunkhorst","year":"2012","unstructured":"Brunkhorst FM, Oppert M, Marx G, Bloos F, Ludewig K, Putensen C, et al. Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. JAMA. 2012;307(22):2390\u20139.","journal-title":"JAMA"},{"issue":"12","key":"790_CR24","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1007\/s00134-016-4504-3","volume":"42","author":"SepNet Critical Care Trials Group","year":"2016","unstructured":"SepNet Critical Care Trials Group. Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study. Intensive Care Med. 2016;42(12):1980\u20139.","journal-title":"Intensive Care Med"},{"issue":"1","key":"790_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s13054-022-04118-6","volume":"26","author":"N Bruse","year":"2022","unstructured":"Bruse N, Kooistra EJ, Jansen A, van Amstel RBE, de Keizer NF, Kennedy JN, et al. Clinical sepsis phenotypes in critically ill COVID-19 patients. Crit Care. 2022;26(1):244.","journal-title":"Crit Care"},{"key":"790_CR26","doi-asserted-by":"publisher","first-page":"775511","DOI":"10.3389\/fmed.2021.775511","volume":"8","author":"H Zhao","year":"2021","unstructured":"Zhao H, Kennedy JN, Wang S, Brant EB, Bernard GR, DeMerle K, et al. Revising host phenotypes of sepsis using microbiology. Front Med. 2021;8:775511.","journal-title":"Front Med"}],"container-title":["Journal of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40560-025-00790-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40560-025-00790-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40560-025-00790-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T19:02:11Z","timestamp":1744657331000},"score":1,"resource":{"primary":{"URL":"https:\/\/jintensivecare.biomedcentral.com\/articles\/10.1186\/s40560-025-00790-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["790"],"URL":"https:\/\/doi.org\/10.1186\/s40560-025-00790-2","relation":{},"ISSN":["2052-0492"],"issn-type":[{"value":"2052-0492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"28 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol of the SISPCT trial was approved by the ethics board of Jena University Hospital (Internal File No. 2242-03\/08). Written informed consent was obtained from all patients or their legal representatives.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. No individual participant data is reported that would require consent to publish from the participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have provided information on potential conflicts of interests directly or indirectly related to the work submitted in the journal\u2019s disclosure forms. FB reported receiving lecture honoraria from biosyn, Gilead, and CSL Behring and public funding for the SISPCT trial to his department by the German Federal Ministry of Education and Research and unrestricted research grants for the SISPCT trial from biosyn and Thermo Fisher Scientific. CS received honorarium as speaker and\/or consultant for Fresenius, Baxter and BBRAUN. GE received honorarium as speaker and\/or consultant for Fresenius. All other authors declared that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}